176 related articles for article (PubMed ID: 1939386)
1. Rapid feasibility studies of tracers for positron emission tomography: high-resolution PET in small animals with kinetic analysis.
Ingvar M; Eriksson L; Rogers GA; Stone-Elander S; Widén L
J Cereb Blood Flow Metab; 1991 Nov; 11(6):926-31. PubMed ID: 1939386
[TBL] [Abstract][Full Text] [Related]
2. Regional kinetic constants and cerebral metabolic rate for glucose in normal human volunteers determined by dynamic positron emission tomography of [18F]-2-fluoro-2-deoxy-D-glucose.
Heiss WD; Pawlik G; Herholz K; Wagner R; Göldner H; Wienhard K
J Cereb Blood Flow Metab; 1984 Jun; 4(2):212-23. PubMed ID: 6609929
[TBL] [Abstract][Full Text] [Related]
3. Noninvasive measurement of cerebral blood flow and glucose metabolic rate in the rat with high-resolution animal positron emission tomography (PET): a novel in vivo approach for assessing drug action in the brains of small animals.
Magata Y; Saji H; Choi SR; Tajima K; Takagaki T; Sasayama S; Yonekura Y; Kitano H; Watanabe M; Okada H
Biol Pharm Bull; 1995 May; 18(5):753-6. PubMed ID: 7492995
[TBL] [Abstract][Full Text] [Related]
4. [Hemocirculation and metabolism in intraventricular tumors: kinetic analysis of glucose metabolism].
Shioya H; Mineura K; Kowada M; Iida H; Murakami M; Ogawa T; Hatazawa J; Uemura K
No Shinkei Geka; 1996 Mar; 24(3):211-9. PubMed ID: 8851949
[TBL] [Abstract][Full Text] [Related]
5. Radiopharmaceuticals for positron emission tomography. Development of new, innovative tracers for measuring the rates of physiologic and biochemical processes.
Gatley SJ; DeGrado TR; Kornguth ML; Holden JE
Acta Radiol Suppl; 1990; 374():7-11. PubMed ID: 1966972
[TBL] [Abstract][Full Text] [Related]
6. Diminished glucose transport in Alzheimer's disease: dynamic PET studies.
Jagust WJ; Seab JP; Huesman RH; Valk PE; Mathis CA; Reed BR; Coxson PG; Budinger TF
J Cereb Blood Flow Metab; 1991 Mar; 11(2):323-30. PubMed ID: 1997504
[TBL] [Abstract][Full Text] [Related]
7. Effect of vascular activity in the determination of rate constants for the uptake of 18F-labeled 2-fluoro-2-deoxy-D-glucose: error analysis and normal values in older subjects.
Evans AC; Diksic M; Yamamoto YL; Kato A; Dagher A; Redies C; Hakim A
J Cereb Blood Flow Metab; 1986 Dec; 6(6):724-38. PubMed ID: 3491827
[TBL] [Abstract][Full Text] [Related]
8. Determination of kinetic rate constants for 2-[18F]fluoro-2-deoxy-D-glucose and partition coefficient of water in conscious macaques and alterations in aging or anesthesia examined on parametric images with an anatomic standardization technique.
Noda A; Takamatsu H; Minoshima S; Tsukada H; Nishimura S
J Cereb Blood Flow Metab; 2003 Dec; 23(12):1441-7. PubMed ID: 14663339
[TBL] [Abstract][Full Text] [Related]
9. Errors introduced by tissue heterogeneity in estimation of local cerebral glucose utilization with current kinetic models of the [18F]fluorodeoxyglucose method.
Schmidt K; Lucignani G; Moresco RM; Rizzo G; Gilardi MC; Messa C; Colombo F; Fazio F; Sokoloff L
J Cereb Blood Flow Metab; 1992 Sep; 12(5):823-34. PubMed ID: 1506447
[TBL] [Abstract][Full Text] [Related]
10. Comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine in head and neck cancer.
Lindholm P; Leskinen-Kallio S; Minn H; Bergman J; Haaparanta M; Lehikoinen P; Någren K; Ruotsalainen U; Teräs M; Joensuu H
J Nucl Med; 1993 Oct; 34(10):1711-6. PubMed ID: 8410288
[TBL] [Abstract][Full Text] [Related]
11. Validation of postinjection transmission measurements for attenuation correction in neurological FDG-PET studies.
Hooper PK; Meikle SR; Eberl S; Fulham MJ
J Nucl Med; 1996 Jan; 37(1):128-36. PubMed ID: 8543982
[TBL] [Abstract][Full Text] [Related]
12. Comparison of [11C]flumazenil and [18F]FDG as PET markers of epileptic foci.
Savic I; Ingvar M; Stone-Elander S
J Neurol Neurosurg Psychiatry; 1993 Jun; 56(6):615-21. PubMed ID: 8509773
[TBL] [Abstract][Full Text] [Related]
13. Determination of 18F-fluoro-2-deoxy-D-glucose rate constants in the anesthetized baboon brain with dynamic positron tomography.
Miyazawa H; Osmont A; Petit-Taboué MC; Tillet I; Travère JM; Young AR; Barré L; MacKenzie ET; Baron JC
J Neurosci Methods; 1993 Dec; 50(3):263-72. PubMed ID: 8152238
[TBL] [Abstract][Full Text] [Related]
14. [Kinetics of glucose metabolism in central neurocytomas].
Shioya H; Mineura K; Sasajima T; Kowada M; Iida H; Ogawa T; Hatazawa J; Uemura K
No To Shinkei; 1995 Oct; 47(10):981-7. PubMed ID: 7577144
[TBL] [Abstract][Full Text] [Related]
15. In vitro positron emission tomography (PET): use of positron emission tracers in functional imaging in living brain slices.
Matsumura K; Bergström M; Onoe H; Takechi H; Westerberg G; Antoni G; Bjurling P; Jacobson GB; Långström B; Watanabe Y
Neurosci Res; 1995 May; 22(2):219-29. PubMed ID: 7566703
[TBL] [Abstract][Full Text] [Related]
16. Image-derived input function from the vena cava for 18F-FDG PET studies in rats and mice.
Lanz B; Poitry-Yamate C; Gruetter R
J Nucl Med; 2014 Aug; 55(8):1380-8. PubMed ID: 24914058
[TBL] [Abstract][Full Text] [Related]
17. A new tool for molecular imaging: the microvolumetric beta blood counter.
Convert L; Morin-Brassard G; Cadorette J; Archambault M; Bentourkia M; Lecomte R
J Nucl Med; 2007 Jul; 48(7):1197-206. PubMed ID: 17574990
[TBL] [Abstract][Full Text] [Related]
18. Estimation of local cerebral glucose utilization by positron emission tomography: comparison of [18F]2-fluoro-2-deoxy-D-glucose and [18F]2-fluoro-2-deoxy-D-mannose in patients with focal brain lesions.
Wienhard K; Pawlik G; Nebeling B; Rudolf J; Fink G; Hamacher K; Stöcklin G; Heiss WD
J Cereb Blood Flow Metab; 1991 May; 11(3):485-91. PubMed ID: 2016357
[TBL] [Abstract][Full Text] [Related]
19. Cerebral glucose utilization measured by positron emission tomography. [1-11C]-D-glucose compared with [2-18F]-2-fluoro-2-deoxy-D-glucose.
Blomqvist G; Stone-Elander S; Halldin C; Roland PE; Swahn CG; Haaparanta M; Solin O; Lindqvist M; Widén L
Acta Radiol Suppl; 1991; 376():171-2. PubMed ID: 1666769
[No Abstract] [Full Text] [Related]
20. A rat head holder for simultaneous scanning of two rats in small animal PET scanners: design, construction, feasibility testing and kinetic validation.
Cheng TE; Yoder KK; Normandin MD; Risacher SL; Converse AK; Hampel JA; Miller MA; Morris ED
J Neurosci Methods; 2009 Jan; 176(1):24-33. PubMed ID: 18824025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
